Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07606495

Impact on Prognosis of Increased Sleep Quality Obtained by Personalized Night-time Nursing Care in Critically Ill Patients

Sleep disturbances are common among intensive care unit (ICU) patients and have been associated with difficult weaning from invasive mechanical ventilation, with an increased risk of endotracheal intubation. Other studies have reported associations between sleep disturbances and prolonged ICU length of stay or the occurrence of delirium. Among the factors contributing to sleep impairment, nighttime care interventions have been identified as a major cause. The management of sleep disorders in the ICU remains complex and often disappointing, and no pharmacological treatment is currently formally recommended. Very recently, a considerable improvement of sleep quantity (+50%) and quality (doubling of deep sleep quantity) has been reported by reorganizing nighttime nursing care according to patients' sleep cycles, using a sleep monitoring medical device.

The objective of this study is to quantify the impact of a better sleep on prognosis. Sleep will be improved using sleep-guided nursing care during nighttime thanks to a real-time sleep monitor (Sleepscan°).

The primary endpoint is the proportion of patients requiring invasive mechanical ventilation or who have died at day 7 after inclusion. The main secondary outcomes include the duration of ICU stay, the number of delirium free-days, the score at a discomfort scale, the score at a post-traumatic stress disorder scale at ICU discharge. Intensive care unit-related costs will be assessed.

A multi-sites, prospective, randomized, open-label, superiority trial with two parallel arms will be conducted.

Awake and conscious patients without continuous sedation, regardless of ventilatory support, with no indication for urgent intubation (<12 hours) and with an expected ICU length of stay greater than 48 hours will be included.

The intervention will consist of sleep-guided nighttime nursing care using the Sleepscan monitor from 7:00 p.m. to 7:00 a.m., every night until ICU discharge or day 7. Sleep-guided nursing care consist in postponing non urgent care (such as temperature measurement…) and avoiding entering the room when patients are asleep. Otherwise, when patients are awake, instructions are to go for all care, to cluster and anticipate nursing care and perform comfort care.

In the control group, sleep will also be recorded using the same device but the tablet will not display the patient's sleep (or awake) status, and nighttime nursing care will be performed according to usual practice and independently of patients' sleep cycles.

Based on our preliminary data and previous studies, it has been estimated that 230 patients per group will be required to detect a reduction in the proportion of patients intubated or deceased at day 7 from 20% in the control group to 10% in the intervention group.

The intention-to-treat analysis population will include all randomized patients.

Demonstrating an improvement in patient prognosis through enhanced sleep quality would represent a major advancement for intensive care medicine. Reducing the need for invasive mechanical ventilation may lead to shorter ICU stays, lower mortality, fewer post-ICU complications, and reduced hospital costs. Demonstrating an improvement in patient prognosis through enhanced sleep quality would represent a major advancement for intensive care medicine. Reducing the need for invasive mechanical ventilation and the incidence of delirium may lead to shorter ICU stays, lower mortality, fewer post-ICU complications, and reduced hospital costs.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients aged 18 years or older admitted to an intensive care unit
  • Conscious patients with a Richmond Agitation-Sedation Scale (RASS) score between -2 and +1
  • Patients without continuous sedation, regardless of ventilatory support
  • No indication for urgent intubation (<12 hours)
  • Informed consent from the relatives or the patient himself

Exclusion criteria

  • Brain tumor or neuropsychiatric disorders affecting sleep
  • Amission for stroke or epilepsy
  • Administration of sleep-modifying medication within 24 hours prior to randomization
  • Patients with skin lesions around the central right and left areas preclunding the placement of the electrodes
  • Patients with expected ICU length of stay less than 48 hours
  • Patients with limitation or withdrawal of life-sustaining therapies
  • Patients already included in the study during a previous hospitalization
  • Patients under law protection (guardianship, conservatorship, or judicial protective measures)
  • People under protection (minors, persons deprived of liberty by a judicial or administrative decision, patients in emergency situations)

Treatment and study plan

Sleepscan device

Device

The Sleepscan® will be installed around 8:00 p.m., for both groups. For the control group, the tablet will not display the sleep/wake status. For the experimental group, the tablet will display the sleep/wake status.

Sleep-guided nursing care

Procedure

Nighttime nursing care will be guided by the Sleepscan device whether the patient is awake or asleep.

When "Prioritize Sleep" signal will be displayed, caregivers may choose to postpone non-urgent care and reduce signal light and sound levels.

When "Prioritize Care" signal will be displayed, caregivers prioritize care will be encouraged.

Primary outcomes

  1. Patient prognosis

    Time frame: Day 7

    Proportion of patients requiring invasive mechanical ventilation or who have died at day 7 after inclusion

Secondary outcomes

  1. ICU length of stay

    Time frame: From date of randomization until the date of discharge from the ICU, assessed up to 90 days

    Number of days in the ICU

  2. Hospital length of stay

    Time frame: Day 90

    Number of days in the hospital

  3. Need for invasive ventilation

    Time frame: Day 7

    Proportion of patients on invasive ventilation at 7 days.

  4. Death in the intensive care unit

    Time frame: From date of randomization until the date of discharge from the ICU, assessed up to 90 days

    Proportion of patients who died in the intensive care unit

  5. Delirium free days

    Time frame: From date of randomization until the date of discharge from the ICU, assessed up to 7 days

    Number of days without delirium, as defined by a negative score on the Confusion Assessment Method for the Intensive Care Unit (CAM-ICU) scale. The CAM-ICU is considered positive (confusion present) if criteria 1 and 2 + 3 or 4 are met.

  6. Delirium requiering treatment

    Time frame: From date of randomization until the date of discharge from the ICU, assessed up to 7 days

    Proportion of patients treated for delirium during their stay in the intensive care unit.

  7. Patient discomfort

    Time frame: Day of discharge from the ICU, assessed up to 90 days

    Comfort score derived from the Scale of Perceived Discomfort in ICU Patients (IPREA) 18, assessed upon discharge from the ICU. The scale ranges from 0 (minimal discomfort) to 100 (maximum discomfort).

  8. Post-traumatic stress symptoms

    Time frame: Day of discharge from the ICU, assessed up to 90 days

    Proportion of patients with post-traumatic stress disorder upon discharge from the intensive care unit, as assessed using the Revised Impact of Events Scale (IES-R) going from 0 (no post traumatic stress disorder) to 88 (severe post traumatic stress disorder).

  9. Insomnia

    Time frame: Day of discharge from the ICU, assessed up to 90 days

    Average severity of sleep disturbances upon discharge from the intensive care unit, as measured by the Insomnia Severity Index (ISI) going from 0 (non insomnia) to 28 (severe insomnia).

  10. ICU-related costs

    Time frame: From date of randomization until the date of discharge from the ICU, assessed up to 90 days

    Average cost of a stay in the intensive care unit from admission to discharge, according to the national cost index

  11. Patient-reported sleep quality

    Time frame: From date of randomization until the date of discharge from the ICU, assessed up to 7 days

    Average sleep quality perceived by the patient during their stay in the intensive care unit, as measured using the Richard-Campbell Sleep Quality Scale. It is based on five questions regarding falling asleep, sleep depth, the number of awakenings, time spent awake, sleep quality, and noise. A sixth question asks respondents to estimate the extent to which noise disturbs their sleep at night. Each item is scored on a scale of 0 (poor sleep quality) to 100 (high sleep quality).

  12. Nurses' workload

    Time frame: From date of randomization until the date of discharge from the ICU, assessed up to 7 days

    Average workload for nurses related to sleep-guided nursing care, as measured using the National Aeronautics and Space Administration Task Load Index (NASA-TLX). Going from 0 (low workload) to 10 (high work load).

  13. Sleep duration

    Time frame: From date of randomization until the date of discharge from the ICU, assessed up to 7 days

    Total sleep time in minutes, as measured by the Sleepscan® device.

  14. Mesured sleep quality

    Time frame: From date of randomization until the date of discharge from the ICU, assessed up to 7 days

    Measured sleep quality will be assessed using three indicators from the Sleepscan® device:

    • The duration of sleep spent in episodes lasting > 10 minutes (in minutes and as a percentage).
    • The duration of deep sleep in stage N3 (in minutes and as a percentage of total sleep time)
    • The duration of REM sleep (in minutes and as a percentage of total sleep time).
  15. Artifacts of the system

    Time frame: From date of randomization until the date of discharge from the ICU, assessed up to 7 days

    Proportion of nights with more than 50% artifacts

Sponsors and collaborators

Lead sponsor

Poitiers University Hospital

Other

Registry information

Official study title

Impact Sur le Pronostic en réanimation d'Une Augmentation du Sommeil Par Soins Nocturnes personnalisés : Essai Clinique randomisé Multicentrique

Acronym: MEDICOSLEEP

Important dates

Study start
2026
Primary completion
2028
Study completion
2028
First posted
May 26, 2026
Registry last updated
May 29, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.